MCK US EQUITY Health Care Health Care Distributors CIK: 927653

McKesson Corporation (MCK) Quant Factor Diagnostic & Fair Value Model

McKesson Corporation (Ticker: MCK) is listed in the Health Care sector (Health Care Distributors). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$1,000.77

-1.14% Latest Close (2026-10-23)

Market Cap: $116.68B

P/E Ratio: 48.6

Momentum Strength 3M / 12M

+17.73%

1M: +15.12% 12M: +25.78%

Quality (ROE) Point-in-Time

+13.66%

Trailing Return on Equity

Technical Trend RSI 14

75.6

SMA50: $910.08 SMA200: $858.72

Valuation Multiplier Trailing

48.6

Premium Multiple (> 30x P/E)

📊 Valuation & Multi-Factor Diagnostic

Premium Multiple (> 30x P/E)

MCK trades at 48.6x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.

Compare in Screener

⚡ Benchmark Factor Strategy

S&P 500 Momentum Alpha Strategy

This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

Strategy Marketplace Open Strategy →

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线多头 (MA20/50) Piotroski F-Score: 5/9 (Moderate Financial Health)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 927653 · 10-K 年报 / 10-Q 季报

Form	Period End	Filing Timestamp (Point-in-Time)	Revenue	Net Income	Operating CF	EPS (Diluted)
10-Q	2026-06-30	2026-08-05	-	$614.00M	-$220.00M	$5.15
10-Q	2026-03-31	2026-08-05	-	-	-	-
10-Q	2025-06-30	2026-08-05	-	$784.00M	-$918.00M	$6.25
10-K	2026-03-31	2026-05-08	-	$4.76B	$6.16B	$38.38
10-K	2025-03-31	2026-05-08	-	$3.29B	$6.08B	$25.72
10-K	2024-03-31	2026-05-08	-	$3.00B	$4.31B	$22.39
10-Q	2025-12-31	2026-02-04	-	$1.19B	$2.73B	$9.59
10-Q	2025-03-31	2026-02-04	-	-	-	-

💡 Methodology & Frequently Asked Questions

Key reference details regarding McKesson Corporation (MCK) valuation multiples, momentum factors, and point-in-time filing conventions.

How should MCK's current valuation multiple be interpreted? ↓

MCK trades at a trailing P/E of 48.6x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.

What are MCK's key momentum and technical factor indicators? ↓

As of the latest close, MCK shows a 1-month return of +15.12%, 3-month return of +17.73%, and 12-month return of +25.78%, with a 14-day RSI of 75.6. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.

What is Point-in-Time (PIT) financial data and why does it matter for MCK? ↓

Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.

How can MCK be incorporated into systematic factor models? ↓

MCK can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.